Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice

August 2005
Croatian Medical Journal;2005, Vol. 46 Issue 4, p720
Academic Journal
Presents an abstract of the study "Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice," by D. Pericic et al.


Related Articles

  • Antiepileptic drugs: New hope on horizon. Starr, Cynthia // Drug Topics;8/2/93, Vol. 137 Issue 15, p30 

    Discusses antiepileptic drugs that are under development and approved by the Food and Drug Administration. Valproic acid; Felbamate; Gabapentin; Lamotrigine; Different types and symptoms of seizures; Controlling seizures while minimizing drug-related adverse reactions as aim of treatment;...

  • A long time coming.  // Drug Topics;8/2/93, Vol. 137 Issue 15, p32 

    Lists different therapeutic drugs under development for the treatment of epilepsy. Carbamazepine; Dezinamide; Diazepam rectal solution; Eterobarb; Felbamate; Fosphenytoin; Gabapentin; Lamotrigine; Oxcarbazepine; Remacemide HCl; Tiagabine; Topiramate; Valproic acid, intravenous; Vigabatrin.

  • Focus on vigabatrin: A second generation antiepileptic agent for treatment of refractory seizure... Campbell, Margaret M. // Hospital Formulary;Mar95, Vol. 30 Issue 3, p143 

    Focuses on vigabatrin, a second generation antiepileptic agent for treatment of refractory seizure disorders. Pharmacology; Pharmacokinetics; Details of clinical trials; Adverse effects; Drug interactions; Dosage and administration. INSET: Formulary considerations..

  • Felbatol approval launches `new era' in epilepsy therapy. Starr, Cynthia // Drug Topics;9/6/93, Vol. 137 Issue 17, p18 

    Reports on the approval of Wallace Laboratories' Felbatol as an antiepileptic by the Food and Drug Administration. Approval of Felbatol as an adjunctive therapy in children aged two years and older and those with Lennox-Gastaut syndrome; Testing results of Felbatol; Adverse reactions reported...

  • Gabapentin approved as adjunct for epilepsy.  // American Family Physician;3/1/1994, Vol. 49 Issue 4, p971 

    Reports on the US Food and Drug Administration's approval of gabapentin as an add-on therapy in the treatment of epilepsy. Dosage; Effectivity; Side effects.

  • Antiepileptic Drug And Glaucoma. Quinn, Christopher J. // Review of Optometry;11/15/2002, Vol. 139 Issue 11, p99 

    Investigates the effects of antiepileptic drug on the treatment of glaucoma. Association of myopia with angle-closure glaucoma; Side effects of topiramate; Susceptibility of the eye to systemic drugs.

  • Enaminones-Versatile Therapeutic Pharmacophores. Further Advances. Eddington, N.D.; Cox, D.S.; Roberts, R.R.; Stables, J.P.; Powell, C.B.; Scott, K.R. // Current Medicinal Chemistry;Apr2000, Vol. 7 Issue 4, p417 

    Enaminones, enamines of �-dicarbonyl compounds, have been know for many years. In our initial account (Current Med. Chem. 1994, 1, 159-175), we reported on the anticonvulsant activity of a series of enaminones, notably methyl 4-[(p-chlorophenyl)amino]-6-methyl- 2-oxo-cyclohex-3-en-1-oate,...

  • Rational Drug Design and the Discovery of the ?2-1,2,3-Triazolines, A Unique Class of Anticonvulsant and Antiischemic Agents. Kadaba, Pankaja K. // Current Medicinal Chemistry;Oct2003, Vol. 10 Issue 20, p2081 

    The ?2- 1,2,3- triazoline anticonvulsants (TRs) may be considered as representing a unique class of �built-in� heterocyclic prodrugs where the active �structure element� is an integral part of the ring system and can be identified only by a knowledge of their chemical...

  • A model for managing epilepsy in a rural community in Africa. Watts, A.E. // BMJ: British Medical Journal (International Edition);3/25/89, Vol. 298 Issue 6676, p805 

    Features the models for managing epilepsy in the rural community in Africa. Discussions on the treatment for epilepsy; Use of anticonvulsant as treatment medicine; Evaluation of the program and use of phenobarbitone as main drug used.

  • Application of Pharmacophore Models for the Design and Synthesis of New Anticonvulsant Drugs. B. Malawska // Mini Reviews in Medicinal Chemistry;Jun2003, Vol. 3 Issue 4, p341 

    The chemical diversity and various mechanisms of action of anticonvulsants make it difficult to identify a common pharmacophore. The present review outlines different pharmacophore models for anticonvulsant activity with emphasis on the development of new drugs. Some of them represent models for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics